Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-24-021127
Filing Date
2024-07-29
Accepted
2024-07-29 19:05:25
Documents
1
Period of Report
2024-07-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3131
  Complete submission text file 0001127602-24-021127.txt   4559
Mailing Address 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4
Business Address 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4 908-541-5456
Bausch & Lomb Corp (Issuer) CIK: 0001860742 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O APPLIED GENETIC TECHNOLOGIES CORP. 14193 NW 119TH TERRACE, SUITE 10 ALACHUA FL 32615
Business Address
Hashad Yehia (Reporting) CIK: 0001877701 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41380 | Film No.: 241153992